<?xml version="1.0" encoding="iso-8859-1"?>
<frameset>
<predicate lemma="result">
<roleset id="result.01" name="" wordnet="2">
<roles>
  <role n="1" descr="Theme, prior condition 
"/>
  <role n="2" descr="Goal, end condition
"/>
</roles>
<example src="MEDLINE" no="1">
<text>
We also report the existence of isoforms of NF-YA which result from differential splicing.  									

</text>
       <arg n="1">[from] differential splicing</arg>
       <arg n="2">the existence of isoforms of NF-YA</arg>
<fdg>
         2	also	also	meta:&gt;3	@ADVL %EH ADV
         3	report	report	main:&gt;0	@+FMAINV %VA V PRES
         4	the	the	det:&gt;5	@DN&gt; %&gt;N DET
         5	existence	existence	obj:&gt;3	@OBJ %NH N NOM SG
         6	of	of	mod:&gt;5	@&lt;NOM-OF %N&lt; PREP
         7	isoforms	isoform	pcomp:&gt;6	@&lt;P %NH &lt;?&gt; N NOM PL
         8	of	of	mod:&gt;7	@&lt;NOM-OF %N&lt; PREP
         9	NF-YA	nf-ya	pcomp:&gt;8	@&lt;P %NH N NOM SG
         10	which	which	subj:&gt;11	@SUBJ %NH &lt;Rel&gt; PRON WH NOM
         11	result	result	mod:&gt;9	@+FMAINV %VA V PRES
         12	from	from	sou:&gt;11	@ADVL %EH PREP
         13	differential	differential	attr:&gt;14	@A&gt; %&gt;N A ABS
         14	splicing	splicing	pcomp:&gt;12	@&lt;P %NH N NOM SG
         15	.     .
</fdg>
</example>
<example src="MEDLINE" no="2">
<text>
Both the 5&apos; and 3&apos; splice site mutations (1060 + 2t--&gt;c and 678-7g--&gt;a, respectively) result in high proportions of mature mRNAs containing introns, which has not been observed for other splicing mutations. 				

</text>
       <arg n="1">Both the 5' and 3' splice site mutations</arg>
       <arg n="2">[in] high proportions of mature mRNAs containing introns</arg>
<fdg>
     2	the	the	det:&gt;3	@DN&gt; %&gt;N DET
     3	5	5		@NH %NH NUM CARD	@SUBJ %NH NUM CARD	@OBJ %NH NUM CARD	@PCOMPL-S %NH NUM CARD	@APP %NH NUM CARD
     4	&apos;	&apos;
     5	and	and		@CC %CC CC
     6	3	3	qn:&gt;8	@QN&gt; %&gt;N NUM CARD
     7	&apos;	&apos;
     8	splice	splice		@NH %NH N NOM SG	@PCOMPL-S %NH N NOM SG	@APP %NH N NOM SG	@&lt;P %NH N NOM SG
     9	site	site	attr:&gt;10	@A&gt; %&gt;N N NOM SG
     10	mutations	mutation		@NH %NH N NOM PL	@SUBJ %NH N NOM PL	@PCOMPL-S %NH N NOM PL	@&lt;P %NH N NOM PL
     11	(	(
     12	1060	1060		@NH %NH NUM CARD	@&lt;NOM %N&lt; NUM CARD	@ADVL %EH NUM CARD
     13	+	+	cc:&gt;12	@CC %CC CC
     14	2t	2t	cc:&gt;12	@NH %NH NUM CARD	@&lt;NOM %N&lt; NUM CARD	@ADVL %EH NUM CARD
     15	--	-
     16	&gt;	&gt;
     17	c	c		@SUBJ %NH ABBR NOM SG	@APP %NH ABBR NOM SG	@&lt;P %NH ABBR NOM SG	@NH %NH ABBR NOM SG	@&lt;NOM %N&lt; ABBR NOM SG
     18	and	and		@CC %CC CC
     19	678-7g	678-7g		@NH %NH &lt;?&gt; N NOM SG	@APP %NH &lt;?&gt; N NOM SG	@&lt;P %NH &lt;?&gt; N NOM SG
     20	--	-
     21	&gt;	&gt;
     22	a	a		@DN&gt; %&gt;N DET SG
     23	,	,
     24	respectively	respectively		@ADVL %EH ADV	@AD-A&gt; %E&gt; ADV
     25	)	)
     26	result	result		@+FMAINV %VA V PRES
     27	in	in	loc:&gt;26	@ADVL %EH PREP
     28	high	high	attr:&gt;29	@A&gt; %&gt;N A ABS
     29	proportions	proportion	pcomp:&gt;27	@&lt;P %NH N NOM PL
     30	of	of	mod:&gt;29	@&lt;NOM-OF %N&lt; PREP
     31	mature	mature	attr:&gt;32	@A&gt; %&gt;N A ABS
     32	mRNAs	mrna	pcomp:&gt;30	@&lt;P %NH &lt;?&gt; N NOM PL
     33	containing	contain	mod:&gt;32	@-FMAINV %VA ING
     34	introns	intron	obj:&gt;33	@OBJ %NH &lt;?&gt; N NOM PL
     35	,	,
     36	which	which	subj:&gt;37	@SUBJ %NH &lt;Rel&gt; PRON WH NOM
     37	has	have	mod:&gt;34	@+FMAINV %VA V PRES SG3
     38	not	not	neg:&gt;39	@ADVL %EH NEG-PART
     39	been	be	v-ch:&gt;40	@-FAUXV %AUX EN
     40	observed	observe	obj:&gt;37	@-FMAINV %VP EN
     41	for	for	ha:&gt;40	@ADVL %EH PREP
     42	other	other	det:&gt;44	@DN&gt; %&gt;N DET
     43	splicing	splicing	attr:&gt;44	@A&gt; %&gt;N A ABS
     44	mutations	mutation	pcomp:&gt;41	@&lt;P %NH N NOM PL
     45	.     .
</fdg>
</example>
<example src="MEDLINE" no="3">
<text>
Sequence analysis of the IDHbeta gene indicates that the difference in the C-terminal 28 amino acids between beta(1) and beta(2) proteins results from alternative splicing of a single transcript.  								

</text>
       <arg n="1">[from] alternative splicing of a single transcript</arg>
       <arg n="2">the difference in the C-terminal 28 amino acids between beta(1) and beta(2) proteins</arg>
<fdg>
         1	Sequence	sequence	attr:&gt;2	@A&gt; %&gt;N N NOM SG
         2	analysis	analysis	subj:&gt;7	@SUBJ %NH N NOM SG
         3	of	of	mod:&gt;2	@&lt;NOM-OF %N&lt; PREP
         4	the	the	det:&gt;6	@DN&gt; %&gt;N DET
         5	IDHbeta	idhbeta	attr:&gt;6	@A&gt; %&gt;N N NOM SG
         6	gene	gene	pcomp:&gt;3	@&lt;P %NH N NOM SG
         7	indicates	indicate	main:&gt;0	@+FMAINV %VA V PRES SG3
         8	that	that	pm:&gt;28	@CS %CS CS
         9	the	the	det:&gt;10	@DN&gt; %&gt;N DET
         10	difference	difference	subj:&gt;28	@SUBJ %NH N NOM SG
         11	in	in	mod:&gt;10	@&lt;NOM %N&lt; PREP
         12	the	the	det:&gt;16	@DN&gt; %&gt;N DET
         13	C-terminal	c-terminal	attr:&gt;14	@A&gt; %&gt;N A ABS
         14	28	28	qn:&gt;16	@QN&gt; %&gt;N NUM CARD
         15	amino	amino	attr:&gt;16	@A&gt; %&gt;N N NOM SG
         16	acids	acid	pcomp:&gt;11	@&lt;P %NH N NOM PL
         17	between	between	mod:&gt;16	@&lt;NOM %N&lt; PREP
         18	beta	beta	pcomp:&gt;17	@&lt;P %NH N NOM SG
         19	(	(
         20	1	1	main:&gt;19	@NH %NH NUM CARD
         21	)	)
         22	and	and	cc:&gt;18	@CC %CC CC
         23	beta	beta	cc:&gt;18	@&lt;P %NH N NOM SG
         24	(	(
         25	2	2	main:&gt;24	@NH %NH NUM CARD
         26	)	)
         27	proteins	protein		@SUBJ %NH N NOM PL	@APP %NH N NOM PL
         28	results	result	obj:&gt;7	@+FMAINV %VA V PRES SG3
         29	from	from	sou:&gt;28	@ADVL %EH PREP
         30	alternative	alternative	attr:&gt;31	@A&gt; %&gt;N A ABS
         31	splicing	splicing	pcomp:&gt;29	@&lt;P %NH N NOM SG
         32	of	of	mod:&gt;31	@&lt;NOM-OF %N&lt; PREP
         33	a	a	det:&gt;35	@DN&gt; %&gt;N DET SG
         34	single	single	attr:&gt;35	@A&gt; %&gt;N A ABS
         35	transcript	transcript	pcomp:&gt;32	@&lt;P %NH N NOM SG
         36	.     .
</fdg>
</example>
<example src="MEDLINE" no="4">
<text>
Alternative splicing of exon 2 (139 nt) and alternative transcriptional initiation result in mRNA species with distinct 5&apos;UTRs. 					

</text>
       <arg n="1">Alternative splicing of exon 2 (139 nt) and alternative transcriptional initiation</arg>
       <arg n="2">[in] mRNA species with distinct 5'UTRs</arg>
<fdg>
         
         1	Alternative	alternative	attr:&gt;2	@A&gt; %&gt;N N NOM SG	@A&gt; %&gt;N A ABS
         2	splicing	splicing		@NH %NH N NOM SG	@SUBJ %NH N NOM SG
         3	of	of	mod:&gt;2	@&lt;NOM-OF %N&lt; PREP
         4	exon	exon	attr:&gt;5	@A&gt; %&gt;N N NOM SG
         5	2	2	pcomp:&gt;3	@&lt;P %NH NUM CARD
         6	(	(
         7	139	139	attr:&gt;8	@A&gt; %&gt;N NUM CARD
         8	nt	nt		@APP %NH ABBR NOM SG	@A&gt; %&gt;N ABBR NOM SG	@NH %NH ABBR NOM SG
         9	)	)
         10	and	and		@CC %CC CC
         11	alternative	alternative	attr:&gt;12	@A&gt; %&gt;N A ABS
         12	transcriptional	transcriptional	attr:&gt;13	@A&gt; %&gt;N A ABS
         13	initiation	initiation	subj:&gt;14	@SUBJ %NH N NOM SG
         14	result	result	main:&gt;0	@+FMAINV %VA V PRES
         15	in	in	loc:&gt;14	@ADVL %EH PREP
         16	mRNA	mrna	attr:&gt;17	@A&gt; %&gt;N ABBR NOM SG
         17	species	species	pcomp:&gt;15	@&lt;P %NH N NOM
         18	with	with		@&lt;NOM %N&lt; PREP	@ADVL %EH PREP
         19	distinct	distinct	attr:&gt;20	@A&gt; %&gt;N A ABS
         20	5&apos;UTRs	5&apos;utr	pcomp:&gt;18	@&lt;P %NH &lt;?&gt; N NOM PL
         21	.     .
</fdg>
</example>
<example src="MEDLINE" no="5">
<text>
Two are missense mutations in exon 2 (G339D and R340C), and the other three alterations (a nonsense mutation, a frameshift, and a splicing mutation) are likely to result in truncated nonfunctional proteins.  								

</text>
       <arg n="1">the other three alterations</arg>
       <arg n="2">[in] truncated nonfunctional proteins</arg>
<fdg>
   	 1	Two	two	subj:>2	@SUBJ %NH NUM CARD    
         2	are	be	main:&gt;0	@+FMAINV %VA V PRES
         3	missense	missense	attr:&gt;4	@A&gt; %&gt;N &lt;?&gt; N NOM SG
         4	mutations	mutation	comp:&gt;2	@PCOMPL-S %NH N NOM PL
         5	in	in	loc:&gt;2	@&lt;NOM %N&lt; PREP	@ADVL %EH PREP
         6	exon	exon	pcomp:&gt;5	@&lt;P %NH N NOM SG
         7	2	2	qn:&gt;9	@QN&gt; %&gt;N NUM CARD
         8	(	(
         9	G339D	g339d	main:&gt;8	@APP %NH N NOM SG
         10	and	and	cc:&gt;9	@CC %CC CC
         11	R340C)	r340c)	cc:&gt;9	@APP %NH N NOM SG
         12	,	,
         13	and	and	cc:&gt;2	@CC %CC CC
         14	the	the		@DN&gt; %&gt;N DET
         15	other	other	det:&gt;17	@DN&gt; %&gt;N DET
         16	three	three	qn:&gt;17	@QN&gt; %&gt;N NUM CARD
         17	alterations	alteration	subj:&gt;31	@SUBJ %NH N NOM PL
         18	(	(
         19	a	a	det:&gt;21	@DN&gt; %&gt;N DET SG
         20	nonsense	nonsense	attr:&gt;21	@A&gt; %&gt;N N NOM SG
         21	mutation	mutation	mod:&gt;17	@APP %NH N NOM SG
         22	,	,
         23	a	a	det:&gt;24	@DN&gt; %&gt;N DET SG
         24	frameshift	frameshift	mod:&gt;21	@APP %NH &lt;?&gt; N NOM SG
         25	,	,
         26	and	and		@CC %CC CC
         27	a	a	det:&gt;29	@DN&gt; %&gt;N DET SG
         28	splicing	splicing	attr:&gt;29	@A&gt; %&gt;N A ABS
         29	mutation	mutation		@NH %NH N NOM SG	@SUBJ %NH N NOM SG	@APP %NH N NOM SG
         30	)	)
         31	are	be	cc:&gt;2	@+FMAINV %VA V PRES
         32	likely	likely	comp:&gt;31	@PCOMPL-S %NH A ABS
         33	to	to	pm:&gt;34	@INFMARK&gt; %AUX INFMARK&gt;
         34	result	result	mod:&gt;32	@-FMAINV %VA V INF
         35	in	in	loc:&gt;34	@ADVL %EH PREP
         36	truncated	truncated	attr:&gt;37	@A&gt; %&gt;N A ABS
         37	nonfunctional	nonfunctional	attr:&gt;38	@A&gt; %&gt;N A ABS
         38	proteins	protein	pcomp:&gt;35	@&lt;P %NH N NOM PL
         39	.     .
</fdg>
</example>
<example src="MEDLINE" no="6">
<text>
Expression of isoform II cDNA in COS7 cells resulted in a marked increase in PAF acetylhydrolase activity. 						

</text>
       <arg n="1">Expression of isoform II cDNA in COS7 cells</arg>
       <arg n="2">[in] a marked increase in PAF acetylhydrolase activity</arg>
<fdg>
     2	of	of	mod:&gt;1	@&lt;NOM-OF %N&lt; PREP
     3	isoform	isoform	attr:&gt;4	@A&gt; %&gt;N &lt;?&gt; N NOM SG
     4	II	ii	attr:&gt;5	@A&gt; %&gt;N NUM ORD
     5	cDNA	cdna	subj:&gt;9	@SUBJ %NH ABBR NOM SG
     6	in	in	mod:&gt;5	@&lt;NOM %N&lt; PREP
     7	COS7	cos7	attr:&gt;8	@A&gt; %&gt;N N NOM SG
     8	cells	cell	pcomp:&gt;6	@&lt;P %NH N NOM PL
     9	resulted	result	main:&gt;0	@+FMAINV %VA V PAST
     10	in	in	loc:&gt;9	@ADVL %EH PREP
     11	a	a	det:&gt;13	@DN&gt; %&gt;N DET SG
     12	marked	marked	attr:&gt;13	@A&gt; %&gt;N A ABS
     13	increase	increase	pcomp:&gt;10	@&lt;P %NH N NOM SG
     14	in	in	phr:&gt;9	@ADVL %EH PREP
     15	PAF	paf	attr:&gt;16	@A&gt; %&gt;N N NOM SG
     16	acetylhydrolase	acetylhydrolase	attr:&gt;17	@A&gt; %&gt;N &lt;?&gt; N NOM SG
     17	activity	activity	pcomp:&gt;14	@&lt;P %NH N NOM SG
     18	.     .
</fdg>
</example>
<example src="MEDLINE" no="7">
<text>
Human mucin gene MUC5B, the 10.7-kb large central exon encodes various alternate subdomains resulting in a super-repeat. 				

</text>
       <arg n="1">various alternate subdomains
</arg>
       <arg n="2">[in] a super-repeat
</arg>
<fdg>
     1	Human	human	attr:&gt;2	@A&gt; %&gt;N A ABS
     2	mucin	mucin	attr:&gt;3	@A&gt; %&gt;N &lt;?&gt; N NOM SG
     3	gene	gene	attr:&gt;4	@A&gt; %&gt;N N NOM SG
     4	MUC5B	muc5b		@NH %NH N NOM SG	@SUBJ %NH N NOM SG	@OBJ %NH N NOM SG
     5	,	,
     6	the	the	det:&gt;12	@DN&gt; %&gt;N DET
     7	10.7	10.7	qn:&gt;12	@QN&gt; %&gt;N NUM CARD
     8	-	-
     9	kb	kb	attr:&gt;10	@A&gt; %&gt;N ABBR NOM SG
     10	large	large	attr:&gt;11	@A&gt; %&gt;N A ABS
     11	central	central	attr:&gt;12	@A&gt; %&gt;N A ABS
     12	exon	exon	subj:&gt;13	@SUBJ %NH N NOM SG
     13	encodes	encode	main:&gt;0	@+FMAINV %VA V PRES SG3
     14	various	various	attr:&gt;15	@A&gt; %&gt;N A ABS
     15	alternate	alternate	attr:&gt;16	@A&gt; %&gt;N A ABS
     16	subdomains	subdomain	obj:&gt;13	@OBJ %NH N NOM PL
     17	resulting	result	mod:&gt;16	@-FMAINV %VA ING
     18	in	in	phr:&gt;17	@ADVL %EH PREP
     19	a	a	det:&gt;20	@DN&gt; %&gt;N DET SG
     20	super-repeat	super-repeat	pcomp:&gt;18	@&lt;P %NH &lt;?&gt; N NOM SG
     21	.     .
</fdg>
</example>
<example src="MEDLINE" no="8">
<text>
The change may cause the heat instability and affect the net charge of the variant subunit, resulting in an electrophoretic LDH-B subunit variant of the fast type.  					

</text>
       <arg n="1">the net charge of the variant subunit
</arg>
       <arg n="2">[in] an electrophoretic LDH-B subunit variant of the fast type
</arg>
<fdg>
         1	The	the	det:&gt;2	@DN&gt; %&gt;N DET
         2	change	change	subj:&gt;3	@SUBJ %NH N NOM SG
         3	may	may	v-ch:&gt;4	@+FAUXV %AUX V AUXMOD
         4	cause	cause	main:&gt;0	@-FMAINV %VA V INF
         5	the	the	det:&gt;7	@DN&gt; %&gt;N DET
         6	heat	heat	attr:&gt;7	@A&gt; %&gt;N N NOM SG
         7	instability	instability	obj:&gt;4	@OBJ %NH N NOM SG
         8	and	and	cc:&gt;4	@CC %CC CC
         9	affect	affect	cc:&gt;4	@-FMAINV %VA V INF
         10	the	the	det:&gt;12	@DN&gt; %&gt;N DET
         11	net	net	attr:&gt;12	@A&gt; %&gt;N N NOM SG
         12	charge	charge	obj:&gt;9	@OBJ %NH N NOM SG
         13	of	of	mod:&gt;12	@&lt;NOM-OF %N&lt; PREP
         14	the	the	det:&gt;16	@DN&gt; %&gt;N DET
         15	variant	variant	attr:&gt;16	@A&gt; %&gt;N N NOM SG
         16	subunit	subunit	pcomp:&gt;13	@&lt;P %NH N NOM SG
         17	,	,
         18	resulting	result	ha:&gt;9	@-FMAINV %VA ING
         19	in	in	loc:&gt;18	@ADVL %EH PREP
         20	an	an	det:&gt;24	@DN&gt; %&gt;N DET SG
         21	electrophoretic	electrophoretic	attr:&gt;22	@A&gt; %&gt;N A ABS
         22	LDH-B	ldh-b	attr:&gt;23	@A&gt; %&gt;N N NOM SG
         23	subunit	subunit	attr:&gt;24	@A&gt; %&gt;N N NOM SG
         24	variant	variant	pcomp:&gt;19	@&lt;P %NH N NOM SG
         25	of	of	mod:&gt;24	@&lt;NOM-OF %N&lt; PREP
         26	the	the	det:&gt;28	@DN&gt; %&gt;N DET
         27	fast	fast	attr:&gt;28	@A&gt; %&gt;N A ABS
         28	type	type	pcomp:&gt;25	@&lt;P %NH N NOM
         29	.     .
</fdg>
</example>
<example src="MEDLINE" no="9">
<text>
Complete sequencing of the prion protein open reading frame of a 68-year-old woman affected by a familial form of Creutzfeldt-Jakob disease (CJD) revealed a new mutation at codon 210 resulting in the substitution of isoleucine for valine.  	

</text>
       <arg n="1">a new mutation at codon 210
</arg>
       <arg n="2">[in] the substitution of isoleucine for valine
</arg>
<fdg>
     1	Complete	complete	attr:&gt;2	@A&gt; %&gt;N A ABS
     2	sequencing	sequencing	subj:&gt;7	@SUBJ %NH N NOM SG
     3	of	of	mod:&gt;2	@&lt;NOM-OF %N&lt; PREP
     4	the	the	det:&gt;6	@DN&gt; %&gt;N DET
     5	prion	prion	attr:&gt;6	@A&gt; %&gt;N N NOM SG
     6	protein	protein	pcomp:&gt;3	@&lt;P %NH N NOM SG
     7	open	open		@+FMAINV %VA V PRES
     8	reading	read	obj:&gt;7	@-FMAINV %VA ING
     9	frame	frame	obj:&gt;8	@OBJ %NH N NOM SG
     10	of	of	mod:&gt;9	@&lt;NOM-OF %N&lt; PREP
     11	a	a	det:&gt;13	@DN&gt; %&gt;N DET SG
     12	68-year-old	68-year-old	attr:&gt;13	@A&gt; %&gt;N A ABS
     13	woman	woman	pcomp:&gt;10	@&lt;P %NH N NOM SG
     14	affected	affect	mod:&gt;13	@-FMAINV %VP EN
     15	by	by	ha:&gt;14	@ADVL %EH PREP
     16	a	a	det:&gt;18	@DN&gt; %&gt;N DET SG
     17	familial	familial	attr:&gt;18	@A&gt; %&gt;N A ABS
     18	form	form	pcomp:&gt;15	@&lt;P %NH N NOM SG
     19	of	of	mod:&gt;18	@&lt;NOM-OF %N&lt; PREP
     20	Creutzfeldt-Jakob	creutzfeldt-#jakob	attr:&gt;21	@A&gt; %&gt;N N NOM SG
     21	disease	disease	pcomp:&gt;19	@&lt;P %NH N NOM SG
     22	(	(
     23	CJD	cjd	mod:&gt;21	@NH %NH ABBR NOM SG
     24	)	)
     25	revealed	reveal		@+FMAINV %VA V PAST
     26	a	a	det:&gt;28	@DN&gt; %&gt;N DET SG
     27	new	new	attr:&gt;28	@A&gt; %&gt;N A ABS
     28	mutation	mutation	obj:&gt;25	@OBJ %NH N NOM SG
     29	at	at	ha:&gt;25	@ADVL %EH PREP
     30	codon	codon	pcomp:&gt;29	@&lt;P %NH N NOM SG
     31	210	210		@QN&gt; %&gt;N NUM CARD
     32	resulting	result		@&lt;P-FMAINV %VA ING	@-FMAINV %VA ING
     33	in	in	phr:&gt;32	@ADVL %EH PREP
     34	the	the	det:&gt;35	@DN&gt; %&gt;N DET
     35	substitution	substitution	pcomp:&gt;33	@&lt;P %NH N NOM SG
     36	of	of	mod:&gt;35	@&lt;NOM-OF %N&lt; PREP
     37	isoleucine	isoleucine	pcomp:&gt;36	@&lt;P %NH &lt;?&gt; N NOM SG
     38	for	for	mod:&gt;37	@&lt;NOM %N&lt; PREP
     39	valine	valine	pcomp:&gt;38	@&lt;P %NH &lt;?&gt; N NOM SG
     40	.     .
</fdg>
</example>
<example src="EMBO" no="1">
<text>
Exon 13 skipping in s1031 animals results in a 543 bp product.

</text>
       <arg n="1">Exon 13 skipping in s1031 animals
</arg>
       <arg n="2">[in] a 543 bp product
</arg>
<fdg>
1	Exon	exon		@NH %NH N NOM SG	@SUBJ %NH N NOM SG	@A&gt; %&gt;N N NOM SG
2	13	13		@QN&gt; %&gt;N NUM CARD
3	skipping	skip		@-FMAINV %VA ING
4	in	in	ha:&gt;3	@ADVL %EH PREP
5	s1031	s1031	attr:&gt;6	@A&gt; %&gt;N N NOM SG
6	animals	animal	pcomp:&gt;4	@&lt;P %NH N NOM PL
7	results	result		@+FMAINV %VA V PRES SG3
8	in	in	phr:&gt;7	@ADVL %EH PREP
9	a	a	det:&gt;10	@DN&gt; %&gt;N DET SG
10	543	543	pcomp:&gt;8	@&lt;P %NH NUM CARD
11	bp	bp	attr:&gt;12	@A&gt; %&gt;N ABBR NOM SG
12	product	product		@SUBJ %NH N NOM SG
13	.     .
</fdg>
</example>
<example src="EMBO" no="2">
<text>
This result also supports our interpretation that let-341 (s1031) represents a loss-of-function rather a severe reduction-of-function mutation, because we expect that fluctuation in the ras-dependent signaling caused by a sli-1 mutation would result in a dramatic change in vulval induction under the condition where a low level activity of LET-23/SEM-5/SOS-1 is present (C.Yoon, C.Chang and P.Sternberg, unpublished).

</text>
       <arg n="1">fluctuation in the ras-dependent signaling </arg>
       <arg n="2">[in] a dramatic change in vulval induction under the condition where a low level activity of LET-23/SEM-5/SOS-1 is present</arg>
<fdg>
1	This	this	det:&gt;2	@DN&gt; %&gt;N DET DEM SG
2	result	result	subj:&gt;4	@SUBJ %NH N NOM SG
3	also	also	meta:&gt;4	@ADVL %EH ADV
4	supports	support		@+FMAINV %VA V PRES SG3
5	our	we	attr:&gt;6	@A&gt; %&gt;N PRON PERS GEN PL1
6	interpretation	interpretation	obj:&gt;4	@OBJ %NH N NOM SG
7	that	that	subj:&gt;12	@SUBJ %NH &lt;Rel&gt; PRON
8	let-341	let-341	qn:&gt;10	@QN&gt; %&gt;N &lt;?&gt; NUM CARD
9	(	(
10	s1031	s1031		@NH %NH N NOM SG
11	)	)
12	represents	represent	mod:&gt;6	@+FMAINV %VA V PRES SG3
13	a	a	det:&gt;14	@DN&gt; %&gt;N DET SG
14	loss-of-function	loss-of-function	obj:&gt;12	@OBJ %NH &lt;?&gt; N NOM SG
15	rather than	rather than	cc:&gt;14	@CC %CC CC
16	a	a	det:&gt;19	@DN&gt; %&gt;N DET SG
17	severe	severe	attr:&gt;18	@A&gt; %&gt;N A ABS
18	reduction-of-function	reduction-of-function	attr:&gt;19	@A&gt; %&gt;N &lt;?&gt; N NOM SG
19	mutation	mutation	cc:&gt;14	@OBJ %NH N NOM SG
20	,	,
21	because	because	pm:&gt;23	@CS %CS CS
22	we	we	subj:&gt;23	@SUBJ %NH PRON PERS NOM PL1
23	expect	expect	cnt:&gt;12	@+FMAINV %VA V PRES
24	that	that	det:&gt;25	@DN&gt; %&gt;N DET DEM SG
25	fluctuation	fluctuation	obj:&gt;23	@OBJ %NH N NOM SG
26	in	in	mod:&gt;25	@&lt;NOM %N&lt; PREP
27	the	the	det:&gt;28	@DN&gt; %&gt;N DET
28	ras	ra	pcomp:&gt;26	@&lt;P %NH &lt;?&gt; N NOM PL
29	-	-
30	dependent	dependent	attr:&gt;31	@A&gt; %&gt;N A ABS
31	signaling	signaling	subj:&gt;37	@SUBJ %NH N NOM SG
32	caused	cause	mod:&gt;31	@-FMAINV %VP EN
33	by	by	ha:&gt;32	@ADVL %EH PREP
34	a	a	det:&gt;36	@DN&gt; %&gt;N DET SG
35	sli-1	sli-1		@QN&gt; %&gt;N &lt;?&gt; NUM CARD
36	mutation	mutation	pcomp:&gt;33	@&lt;P %NH N NOM SG
37	would	would	v-ch:&gt;38	@+FAUXV %AUX V AUXMOD
38	result	result		@-FMAINV %VA V INF
39	in	in	loc:&gt;38	@ADVL %EH PREP
40	a	a	det:&gt;42	@DN&gt; %&gt;N DET SG
41	dramatic	dramatic	attr:&gt;42	@A&gt; %&gt;N A ABS
42	change	change	pcomp:&gt;39	@&lt;P %NH N NOM SG
43	in	in	phr:&gt;38	@ADVL %EH PREP
44	vulval	vulval	attr:&gt;45	@A&gt; %&gt;N A ABS
45	induction	induction	pcomp:&gt;43	@&lt;P %NH N NOM SG
46	under	under	mod:&gt;45	@&lt;NOM %N&lt; PREP
47	the	the	det:&gt;48	@DN&gt; %&gt;N DET
48	condition	condition	pcomp:&gt;46	@&lt;P %NH N NOM SG
49	where	where		@ADVL %EH ADV WH
50	a	a	det:&gt;53	@DN&gt; %&gt;N DET SG
51	low	low	attr:&gt;52	@A&gt; %&gt;N A ABS
52	level	level	attr:&gt;53	@A&gt; %&gt;N N NOM SG
53	activity	activity		@APP %NH N NOM SG
54	of	of	mod:&gt;53	@&lt;NOM-OF %N&lt; PREP
55	LET-23	let-23	pcomp:&gt;54	@&lt;P %NH N NOM SG
56	/	/	
57	SEM-5	sem-5		@APP %NH N NOM SG
58	/	/	
59	SOS-1	sos-1	subj:&gt;60	@SUBJ %NH N NOM SG
60	is	be		@+FMAINV %VA V PRES SG3
61	present	present		@PCOMPL-S %NH A ABS	@A&gt; %&gt;N A ABS	@&lt;NOM %N&lt; A ABS
62	(	(
63	C.Yoon	c.yoon		@NH %NH N NOM SG
64	,	,
65	C.Chang	c.chang	cc:&gt;63	@NH %NH N NOM SG
66	and	and	cc:&gt;65	@CC %CC CC
67	P.Sternberg	p.sternberg	cc:&gt;65	@NH %NH N NOM SG
68	,	,
69	unpublished	unpublished	mod:&gt;67	@APP %NH A ABS
70	)	)
71	.     .
</fdg>
</example>
<example src="EMBO" no="3">
<text>
A role for SOS-1 in FGFR-mediated signaling during development Hyperactive EGL-15 FGF receptor signaling, conferred by either an activated egl-15 or a lf clr-1 mutation, results in a Clr phenotype.

</text>
       <arg n="1">A role for SOS-1 in FGFR-mediated signaling during development Hyperactive EGL-15 FGF receptor signaling</arg>
       <arg n="2">[in] a Clr phenotype</arg>
<fdg>

1	A	a	det:&gt;2	@DN&gt; %&gt;N DET SG
2	role	role	subj:&gt;30	@SUBJ %NH N NOM SG
3	for	for	mod:&gt;2	@&lt;NOM %N&lt; PREP
4	SOS-1	sos-1	pcomp:&gt;3	@&lt;P %NH N NOM SG
5	in	in	mod:&gt;4	@&lt;NOM %N&lt; PREP
6	FGFR	fgfr	pcomp:&gt;5	@&lt;P %NH N NOM SG
7	-	-
8	mediated	mediate		@-FMAINV %VP EN
9	signaling	signal	obj:&gt;8	@-FMAINV %VA ING
10	during	during	ha:&gt;9	@ADVL %EH PREP
11	development	development	attr:&gt;12	@A&gt; %&gt;N N NOM SG
12	Hyperactive	hyperactive	attr:&gt;13	@A&gt; %&gt;N A ABS
13	EGL-15	egl-15	attr:&gt;14	@A&gt; %&gt;N N NOM SG
14	FGF	fgf	attr:&gt;15	@A&gt; %&gt;N ABBR NOM SG
15	receptor	receptor	attr:&gt;16	@A&gt; %&gt;N N NOM SG
16	signaling	signaling	pcomp:&gt;10	@&lt;P %NH N NOM SG
17	,	,
18	conferred	confer	mod:&gt;16	@-FMAINV %VP EN
19	by	by	ha:&gt;18	@ADVL %EH PREP
20	either	either		@ADVL %EH ADV
21	an	an		@DN&gt; %&gt;N DET SG
22	activated	activated	attr:&gt;23	@A&gt; %&gt;N A ABS
23	egl-15	egl-15		@NH %NH &lt;?&gt; NUM CARD	@OBJ %NH &lt;?&gt; NUM CARD	@&lt;P %NH &lt;?&gt; NUM CARD	@QN&gt; %&gt;N &lt;?&gt; NUM CARD	@ADVL %EH &lt;?&gt; NUM CARD
24	or	or		@CC %CC CC
25	a	a		@DN&gt; %&gt;N DET SG
26	lf	lf		@SUBJ %NH ABBR NOM SG	@OBJ %NH ABBR NOM SG	@A&gt; %&gt;N ABBR NOM SG	@&lt;P %NH ABBR NOM SG	@NH %NH ABBR NOM SG
27	clr-1	clr-1		@QN&gt; %&gt;N &lt;?&gt; NUM CARD
28	mutation	mutation		@NH %NH N NOM SG	@SUBJ %NH N NOM SG	@OBJ %NH N NOM SG	@&lt;P %NH N NOM SG
29	,	,
30	results	result	main:&gt;0	@+FMAINV %VA V PRES SG3
31	in	in	loc:&gt;30	@ADVL %EH PREP
32	a	a	det:&gt;34	@DN&gt; %&gt;N DET SG
33	Clr	clr	attr:&gt;34	@A&gt; %&gt;N &lt;?&gt; N NOM SG
34	phenotype	phenotype	pcomp:&gt;31	@&lt;P %NH N NOM SG
35	.     .
</fdg>
</example>
<example src="EMBO" no="4">
<text>
Decreased EGL-15 signaling, conferred by a partial lf egl-15 mutation, results in a scrawny body morphology phenotype(Kokel et al., 1998).

</text>
       <arg n="1">Decreased EGL-15 signaling
</arg>
       <arg n="2">[in] a scrawny body morphology phenotype
</arg>
<fdg>
1	Decreased	decreased	attr:&gt;2	@A&gt; %&gt;N A ABS
2	EGL-15	egl-15	attr:&gt;3	@A&gt; %&gt;N N NOM SG
3	signaling	signaling	subj:&gt;13	@SUBJ %NH N NOM SG
4	,	,
5	conferred	confer	mod:&gt;3	@-FMAINV %VP EN
6	by	by	ha:&gt;5	@ADVL %EH PREP
7	a	a	det:&gt;9	@DN&gt; %&gt;N DET SG
8	partial	partial	attr:&gt;9	@A&gt; %&gt;N A ABS
9	lf	lf	pcomp:&gt;6	@&lt;P %NH ABBR NOM SG
10	egl-15	egl-15		@QN&gt; %&gt;N &lt;?&gt; NUM CARD
11	mutation	mutation	obj:&gt;5	@OBJ %NH N NOM SG
12	,	,
13	results	result	main:&gt;0	@+FMAINV %VA V PRES SG3
14	in	in	phr:&gt;13	@ADVL %EH PREP
15	a	a	det:&gt;19	@DN&gt; %&gt;N DET SG
16	scrawny	scrawny	attr:&gt;17	@A&gt; %&gt;N A ABS
17	body	body	attr:&gt;18	@A&gt; %&gt;N N NOM SG
18	morphology	morphology	attr:&gt;19	@A&gt; %&gt;N N NOM SG
19	phenotype	phenotype	pcomp:&gt;14	@&lt;P %NH N NOM SG
20	(	(
21	Kokel	kokel	main:&gt;20	@APP %NH &lt;?&gt; N NOM SG
22	et	et		@CC %CC CC
23	al.	al.		@SUBJ %NH ABBR NOM SG	@OBJ %NH ABBR NOM SG	@APP %NH ABBR NOM SG	@A&gt; %&gt;N ABBR NOM SG	@&lt;P %NH ABBR NOM SG	@NH %NH ABBR NOM SG	@&lt;NOM %N&lt; ABBR NOM SG
24	,	,
25	1998	1998		@NH %NH NUM CARD	@SUBJ %NH NUM CARD	@OBJ %NH NUM CARD	@&lt;P %NH NUM CARD	@A&gt; %&gt;N NUM CARD	@&lt;NOM %N&lt; NUM CARD	@ADVL %EH NUM CARD
26	)	)
27	.     .
</fdg>
</example>
<example src="EMBO" no="5">
<text>
One variant results from failure to use the normal splice donor site of intron 12.

</text>
       <arg n="1">One variant
</arg>
       <arg n="2">[from] failure to use the normal splice donor site of intron 12
</arg>
<fdg>
1	One	one	qn:&gt;2	@QN&gt; %&gt;N NUM CARD
2	variant	variant	subj:&gt;3	@SUBJ %NH N NOM SG
3	results	result	main:&gt;0	@+FMAINV %VA V PRES SG3
4	from	from	sou:&gt;3	@ADVL %EH PREP
5	failure	failure	pcomp:&gt;4	@&lt;P %NH N NOM SG
6	to	to	pth:&gt;4	@ADVL %EH PREP
7	use	use	pcomp:&gt;6	@&lt;P %NH N NOM SG
8	the	the	det:&gt;12	@DN&gt; %&gt;N DET
9	normal	normal	attr:&gt;10	@A&gt; %&gt;N A ABS
10	splice	splice	attr:&gt;11	@A&gt; %&gt;N N NOM SG
11	donor	donor	attr:&gt;12	@A&gt; %&gt;N N NOM SG
12	site	site		@APP %NH N NOM SG
13	of	of	mod:&gt;12	@&lt;NOM-OF %N&lt; PREP
14	intron	intron	attr:&gt;15	@A&gt; %&gt;N N NOM SG
15	12	12	pcomp:&gt;13	@&lt;P %NH NUM CARD
16	.     .
</fdg>
</example>
</roleset>
</predicate>
</frameset>
